loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

Technical details about Mivavotinib, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Tak-659, 1312691-33-0, Tak-659 free base, Mivavotinib [usan], Tak-659f, Tak659
Molecular Formula
C17H21FN6O
Molecular Weight
344.4  g/mol
InChI Key
MJHOMTRKVMKCNE-NWDGAFQWSA-N
FDA UNII
8QR88H79VX

Mivavotinib is an inhibitor of spleen tyrosine kinase (syk), with potential anti-inflammatory, immunomodulating, and antineoplastic activities. Upon administration, mivavotinib may inhibit the activity of syk, which abrogates downstream B-cell receptor (BCR) signaling and leads to an inhibition of B-cell activation, chemotaxis, adhesion and proliferation. Syk, a BCR-associated non-receptor tyrosine kinase that mediates diverse cellular responses, including proliferation, differentiation, and phagocytosis, is expressed in hematopoietic tissues and is often overexpressed in hematopoietic malignancies.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one
2.1.2 InChI
InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1
2.1.3 InChI Key
MJHOMTRKVMKCNE-NWDGAFQWSA-N
2.1.4 Canonical SMILES
CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4N
2.1.5 Isomeric SMILES
CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)N[C@@H]4CCCC[C@@H]4N
2.2 Other Identifiers
2.2.1 UNII
8QR88H79VX
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Tak-659

2.3.2 Depositor-Supplied Synonyms

1. Tak-659

2. 1312691-33-0

3. Tak-659 Free Base

4. Mivavotinib [usan]

5. Tak-659f

6. Tak659

7. 8qr88h79vx

8. Chembl3979920

9. 6-[[(1r,2s)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one

10. 3h-pyrrolo(3,4-c)pyridin-3-one, 6-(((1r,2s)-2-aminocyclohexyl)amino)-7-fluoro-1,2-dihydro-4-(1-methyl-1h-pyrazol-4-yl)-

11. 3h-pyrrolo[3,4-c]pyridin-3-one, 6-[[(1r,2s)-2-aminocyclohexyl]amino]-7-fluoro-1,2-dihydro-4-(1-methyl-1h-pyrazol-4-yl)-

12. 6-(((1r,2s)-2-aminocyclohexyl)amino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1,2-dihydro-3h-pyrrolo[3,4-c]pyridin-3-one

13. 6-((1r,2s)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo(3,4-c)pyridin-3(2h)-one

14. 6-((1r,2s)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo[3,4-c]pyridin-3(2h)-one

15. 6-{[(1r,2s)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1,2-dihydro-3h-pyrrolo[3,4-c]pyridin-3-one

16. Mivavotinib [inn]

17. Mivavotinib (usan/inn)

18. Tak659 2hcl

19. Unii-8qr88h79vx

20. Mivavotinib [who-dd]

21. Tak-659 2hcl

22. Gtpl9600

23. Schembl1987799

24. Tak-659 Free Base(mivavotinib)

25. Bcp28883

26. Ex-a1401

27. Bdbm50204290

28. Cb-659

29. Nsc791967

30. Nsc791968

31. Who 10836

32. Nsc-791967

33. Nsc-791968

34. Compound 3b [pmid: 27839918]

35. Ac-35463

36. Hy-100867

37. Cs-0020533

38. D11789

39. 1312691-41-0

40. Cis-6-(2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo[3,4-c]pyridin-3(2h)-one

2.4 Create Date
2011-07-25
3 Chemical and Physical Properties
Molecular Weight 344.4 g/mol
Molecular Formula C17H21FN6O
XLogP30.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass344.17608748 g/mol
Monoisotopic Mass344.17608748 g/mol
Topological Polar Surface Area97.9 Ų
Heavy Atom Count25
Formal Charge0
Complexity508
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY